BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1168 related articles for article (PubMed ID: 16918235)

  • 1. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormesis [biological effects of low-level exposure (B.E.L.L.E.)] and dermatology.
    Thong HY; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):329-41. PubMed ID: 18058307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health risk of low-dose pesticides mixtures: a review of the 1985-1998 literature on combination toxicology and health risk assessment.
    Carpy SA; Kobel W; Doe J
    J Toxicol Environ Health B Crit Rev; 2000; 3(1):1-25. PubMed ID: 10711323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level chemical sensitivity: a perspective from behavioral toxicology.
    Weiss B
    Toxicol Ind Health; 1994; 10(4-5):605-17. PubMed ID: 7778118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships.
    Swenberg JA; Fryar-Tita E; Jeong YC; Boysen G; Starr T; Walker VE; Albertini RJ
    Chem Res Toxicol; 2008 Jan; 21(1):253-65. PubMed ID: 18161944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response considerations in risk assessment--an overview of recent ILSI activities.
    Holsapple MP; Wallace KB
    Toxicol Lett; 2008 Aug; 180(2):85-92. PubMed ID: 18588961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
    Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
    el-Masri HA; Reardon KF; Yang RS
    Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response assessment strategies for endocrine-active compounds.
    Barton HA; Andersen ME
    Regul Toxicol Pharmacol; 1997 Jun; 25(3):292-305. PubMed ID: 9237331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to multiple environmental agents and their effect.
    Koppe JG; Bartonova A; Bolte G; Bistrup ML; Busby C; Butter M; Dorfman P; Fucic A; Gee D; van den Hazel P; Howard V; Kohlhuber M; Leijs M; Lundqvist C; Moshammer H; Naginiene R; Nicolopoulou-Stamati P; Ronchetti R; Salines G; Schoeters G; ten Tusscher G; Wallis MK; Zuurbier M
    Acta Paediatr Suppl; 2006 Oct; 95(453):106-13. PubMed ID: 17000577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of the maximum tolerated dose (MTD) and maximum tolerated concentration (MTC) concept in aquatic toxicology.
    Hutchinson TH; Bögi C; Winter MJ; Owens JW
    Aquat Toxicol; 2009 Feb; 91(3):197-202. PubMed ID: 19124163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and dosimetry of toxicologic responses.
    Doull J
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S55-7. PubMed ID: 8921557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of non-linear (dose-dependent) pharmacokinetics in hazard assessment.
    Watanabe PG; Young JD; Gehring PJ
    J Environ Pathol Toxicol; 1977; 1(2):147-59. PubMed ID: 553128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.